Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder

被引:6
|
作者
Wang, Liang-Jen [1 ,2 ]
Lee, Sheng-Yu [3 ,4 ]
Chou, Wen-Jiun [1 ,2 ]
Lee, Min-Jing [1 ,2 ]
Tsai, Ching-Shu [1 ,2 ]
Lee, Tung-Liang [5 ]
Yang, Chun-Ju [6 ]
Yang, Kang-Chung [6 ]
Chen, Chih-Ken [6 ,7 ,8 ]
Shyu, Yu-Chiau [6 ,9 ,10 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan
[2] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[3] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Sch Med, Grad Inst Med, Dept Psychiat,Coll Med, Kaohsiung, Taiwan
[5] Soochow Univ, Dept Microbiol, Taipei, Taiwan
[6] Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung 204, Taiwan
[7] Chang Gung Mem Hosp, Dept Psychiat, Keelung, Taiwan
[8] Chang Gung Univ, Coll Med, Keelung, Taiwan
[9] Acad Sinica, Inst Mol Biol, Taipei, Taiwan
[10] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan
关键词
ADHD; comorbidity; testosterone; epidemiology; psychostimulant; ENDOCRINE DISRUPTORS; STIMULANT MEDICATION; TESTOSTERONE; EXPOSURE; PARAMETERS; CHILDREN; SYSTEM; BRAIN;
D O I
10.1089/cap.2018.0126
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Treating attention-deficit/hyperactivity disorder (ADHD) with methylphenidate (MPH) has become increasingly common, while both animal studies and case reports have previously suggested that MPH may exert adverse effects on the reproductive system or gonadal hormones. This study aims to investigate whether long-term MPH treatment of boys with ADHD can induce testicular dysfunction (TD). Methods: A nationwide cohort that included 59,746 boys diagnosed with ADHD and 52,008 healthy subjects retrieved from the National Health Insurance database in Taiwan was also observed between 1999 and 2011. TD was defined by the International Classification of Diseases, 9th revision, Clinical Modifications codes (257.0, 257.1, 257.2, 257.8, or 257.9). Cumulative time of MPH use was categorized into nonuse, short-term use (1-365 days), and long-term use (>365 days). We compared the rate of TD diagnosis between ADHD patients and controls and analyzed the risk of developing a TD after MPH treatment. Results: Compared with the control group (0.06%), the ADHD group had a higher comorbidity rate of TD (0.14%) (adjusted odds ratio [aOR] = 1.95, 95% confidence interval [95% CI]: 1.26-3.04, p = 0.003). However, MPH did not significantly influence the risk of developing TD (adjusted hazard ratio = 1.40, 95% CI: 0.77-2.54, p = 0.272). Compared with ADHD boys without MPH treatment, patients who were prescribed short-term MPH (aOR = 0.96, 95% CI: 0.51-1.82, p = 0.900) and long-term MPH (aOR = 1.40, 95% CI: 0.69-2.83, p = 0.351) showed no significance associated with an increased risk of developing TD. Conclusions: Our nationwide cohort showed that long-term treatment with MPH has no harmful effect on the testosterone function of ADHD patients. However, due to the increased comorbidity rate of ADHD and TD, early recognition and detection of TD in ADHD children have the potential to change the trajectory of TD morbidity later in life.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 50 条
  • [1] METHYLPHENIDATE AND ATTRIBUTIONS IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    PELHAM, WE
    VANNATTA, K
    GNAGY, EM
    LICHT, BG
    GREENSLADE, KE
    GREINER, AR
    MURPHY, DA
    MILICH, R
    VODDEHAMILTON, M
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1992, 60 (02) : 282 - 292
  • [2] Response to methylphenidate in boys with attention-deficit hyperactivity disorder
    Zeiner, P
    Bryhn, G
    Bjercke, C
    Truyen, K
    Strand, G
    ACTA PAEDIATRICA, 1999, 88 (03) : 298 - 303
  • [3] METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTES SYNDROME
    SVERD, J
    GADOW, KD
    PAOLICELLI, LM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1989, 28 (04): : 574 - 579
  • [4] Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
    Clara I. Gomez-Sanchez
    Juan J. Carballo
    Rosa Riveiro-Alvarez
    Victor Soto-Insuga
    Maria Rodrigo
    Ignacio Mahillo-Fernandez
    Francisco Abad-Santos
    Rafael Dal-Ré
    Carmen Ayuso
    Scientific Reports, 7
  • [5] Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
    Gomez-Sanchez, Clara I.
    Carballo, Juan J.
    Riveiro-Alvarez, Rosa
    Soto-Insuga, Victor
    Rodrigo, Maria
    Mahillo-Fernandez, Ignacio
    Abad-Santos, Francisco
    Dal-Re, Rafael
    Ayuso, Carmen
    SCIENTIFIC REPORTS, 2017, 7
  • [7] Editorial: On the Safety of Long-term Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder in Early Childhood
    Vitiello, Benedetto
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (01): : 32 - 33
  • [8] METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTES SYNDROME - COMMENTARY
    COHEN, DJ
    LECKMAN, JF
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1989, 28 (04): : 580 - 582
  • [9] Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder
    Battel, Lucas
    Kieling, Renata R.
    Kieling, Christian
    Anes, Mauricio
    Aurich, Nathassia Kadletz
    da Costa, Jaderson Costa
    Rohde, Luis Augusto
    Franco, Alexandre Rosa
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (06) : 555 - +